Author

Satoshi Tanida 1

1 Nagoya City University Hospital

ADALIMUMAB ACHIEVES COMPLETE REMISSION AT 52 WEEKS IN JAPANESE PATIENTS WITH INTESTINAL BEHÇET'S DISEASE

Fumihito Hirai, Satoshi Tanida, Nagamu Inoue, Makoto Naganuma, Anne Camez, Bidan Huang, Vipin Arora, Morio Ozawa, Toshifumi Hibi, Roopal B Thakkar

EFFECTS OF HEPARIN BRIDGING THERAPY ON POST-POLYPECTOMY BLEEDING AND THROMBOEMBOLIC RISKS IN PATIENT UNDERGOING COLONOSCOPIC POLYPECTOMY

noriyuki hayashi, Hiromi Kataoka, Takahito Katano, Keiji Ozeki, yasuyuki okamoto, Tsutomu Mizoshita, Takaya Shimura, E. Kubota, Satoshi Tanida, T. Joh

EFFICACY AND SAFETY OF INFLIXIMAB SALVAGE THERAPY FOR PATIENTS WITH ULCERATIVE COLITIS WHO FAILED TO TACROLIMUS

Hironobu Tsukamoto, Satoshi Tanida, Tsutomu Mizoshita, Keiji Ozeki

EFFICACY AND SAFETY OF UPADACITINIB AS AN INDUCTION THERAPY FOR PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE PHASE 2B STUDY U-ACHIEVE

William Sandborn, Subrata Ghosh, Julian Panés, Stefan Schreiber, Geert R. D'Haens, Satoshi Tanida, Jesse Siffledeen, Jose Enejosa, Wen Zhou, Ahmed A. Othman, Bidan Huang, Peter D.R. Higgins

Item 1 - 4 / 10
1